Functional Neuropathology in Parkinson’s Disease

European Neurology

Volumn 38, Issue , 1997, Pages 21-25

  Gibb, William R G ^a  

^a SOUTHAMPTON GENERAL HOSPITAL   (United Kingdom)

Author keywords

Lewy bodies; Melanin; Parkinson s disease; Striatum; Substantia nigra

Indexed keywords

DOPAMINE;

AKINESIA; BASAL GANGLION; CHOREA; CONFERENCE PAPER; CORPUS STRIATUM; FRONTAL CORTEX; GLOBUS PALLIDUS; MOTOR CORTEX; NEUROPATHOLOGY; NIGRONEOSTRIATAL SYSTEM; PARKINSON DISEASE; PARKINSONISM; PATHOPHYSIOLOGY; PRIORITY JOURNAL; SUBSTANTIA NIGRA; SUBTHALAMIC NUCLEUS; THALAMUS;

BASAL GANGLIA; BRAIN MAPPING; CEREBRAL CORTEX; DOPAMINE; HUMANS; NERVE DEGENERATION; NERVE NET; NEURAL PATHWAYS; PARKINSON DISEASE; THALAMIC NUCLEI;

EID: 0030686550     PISSN: 00143022     EISSN: 14219913     Source Type: Journal    
DOI: 10.1159/000113472     Document Type: Article

References (17)

1. Gibb WRG, Lccs AJ: The relevance of the Levvy body to the pathogenesis of idiopathic Parkinson's disease, J Neurol Neurosurg Psychiatry 1988;51:745-752.
2. Goldmann JE, Yen SH, Chiu FC, Peress NS: Lewy bodies of Parkinson’s disease contain neurofilamcnt antigens, Science 1983:221: 1082-1084.
3. Rajput AH, Gibb WRG, Zhong XH, Shannak KS, Kish S, Chang LG, Homykiewicz O: Dopa-responsive dystonia: Pathological and biochemical observations in a case, Ann Neurol 1994:35:396-402.
4. Gibb WRG, Lees AJ: The significance of the I, cwy body in the diagnosis of idiopathic Parkinson's disease, Neuropathol Appl Neurobiol 1989:15:27-44.
5. Marsden CD, Obcso JA: The functions of the basal ganglia and the paradox of stereotaxic surgery in Parkinson's disease, Brain 1994:117: 877-897.
6. Jenkins IH, Fernandez W, Playford ED, Lees AJ, Frackowiak RSJ, Passingham RE, Brooks DJ: Impaired activation of the supplementary motor area in Parkinson’s disease is reversed when akinesia is treated with apomorphine, Ann Neurol 1992;32:749-757.
7. Hassler R: Zur Normalanatomie der Substantia nigra, J Psychol Neurol 1937;48:1-55.
8. Olszewski J, Baxter D: Cytoarchitecture of the Human Brain Stem, Basel, Karger, 1954.
9. Gibb WRG: Neuropathology of the substantia nigra, Eur Neurol 1991;31 (suppl 1):48-59.
10. Gibb WRG, Lees AJ: Anatomy, pigmentation, ventral and dorsal subpopulations of the substantia nigra, and differential cell death in Parkinson’s disease, J Neurol Neurosurg Psychiatry 1991;54:388-396.
11. Penney JB, Young AB: Striatal inhomogeneities and basal ganglia function, Mov Disord 1986;1:3-15.
12. Gibb WRG, Lees AJ: Pathological clues to the cause of Parkinson's disease; in Marsden CD, Fahn S (eds): Movement Disorders 3. London, Butterworth Hcinemann, 1994. pp 147-166.
13. Turner BH, Wilson JS, McKenzie JC, Richland N: MPTP produces a pattern of nigro-striatal degeneration which coincides with the mosaic organisation of the caudate nucleus, Brain Res 1988:473:60-64.
14. Fcamley JM, Lees AJ: Ageing is not involved in the pathophysiology of Parkinon’s disease, Brain 1991;114:2283-2301.
15. Yokochi M, Narabayashi H, lizuka R, Nagatsu T: Juvenile parkinsonism: Some clinical, pharmacological, and ncuropathological aspects, Adv Neurol 1984:40:407-413.
16. Gibb WRG, Narabayashi H, Yokochi M, lizuka R, Lccs AJ: New pathologic observations in juvenile onset parkinsonism with dystonia, Neurology 1991;41:820-822.
17. Hirsch E, Graybiel AM, Agid YA: Mclanizcd dopaminergic neurons arc differentially susceptible to degeneration in Parkinon’s disease, Nature 1988:334:345-348.